drugset / Trial / NCT01257061

Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment

NCT01257061

Phase 3 Completed 310 enrolled EMS
RandomizedParallel-groupTriple-blindTreatment

Summary

Atopic dermatitis is a recurrent pruritic skin disorder which has a significant morbidity and impaired quality of life due specially pruritus and physical visible skin lesions. The propose of this trial is evaluate the effectiveness of clemastine fumarate 1, 0 mg/g + dexamethasone 0, 5 mg/g compared to dexchlorpheniramine maleate 10 mg/g in eczema treatment.

Timeline

Start
2012-09-06
Primary completion
2013-04-30
Completion
2013-08-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Clemastine Small molecule 1 unknown Topical
Subject Dexamethasone Small molecule 0.5 unknown Topical
Subject Dexchlorpheniramine Unknown 10 unknown Topical

Indications